Log In
Print
BCIQ
Print
Print this Print this
 

microtubule stabilizer (BMS-241027)

  Manage Alerts
Collapse Summary General Information
Company Bristol-Myers Squibb Co.
DescriptionMicrotubule stabilizer that prevents the production of abnormal Tau
Molecular Target Microtubule-associated protein tau (MAPT) (tau) (FTDP-17)
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationAlzheimer's disease (AD)
Indication DetailsTreat mild Alzheimer's disease (AD)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today